Momenta Pharmaceuticals Announces Date of First Quarter 2014 Financial Results Conference Call and Webcast
April 15 2014 - 4:05PM
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, will release its financial results for the first
quarter ended March 31, 2014 before the U.S. financial markets open
on Tuesday, May 6, 2014.
Management will host a conference call on that date at 10:00
a.m. EST to discuss these results and provide an update on the
company. To access the call, please dial (877) 224-9084 (domestic)
or (720) 545-0022 (international) prior to the scheduled conference
call time and provide the access code 24579515. A live webcast of
the call will be available on the "Investors" section of the
company's website, www.momentapharma.com. Please go to the site at
least 15 minutes prior to the call in order to register, download,
and install any necessary software. An archived version of the
webcast will be posted on the Momenta website approximately two
hours after the call.
About Momenta Momenta Pharmaceuticals is
a biotechnology company specializing in the detailed structural
analysis of complex mixture drugs and is headquartered in
Cambridge, MA. Momenta is applying its technology to the
development of generic versions of complex drugs, biosimilar and
potentially interchangeable biologics, and to the discovery and
development of novel drugs.
To receive additional information about Momenta, please visit
the website at www.momentapharma.com, which does not form a part of
this press release. The company's logo, trademarks, and service
marks are the property of Momenta Pharmaceuticals, Inc. All other
trade names, trademarks, or service marks are property of their
respective owners.
CONTACT: Momenta Pharmaceuticals, Inc.
ir@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024